<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201215</date><key>pmc.key</key><document><id>2722583</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1038/ejcn.2009.11</infon><infon key="article-id_manuscript">UKMS3579</infon><infon key="article-id_pmc">2722583</infon><infon key="article-id_pmid">19259112</infon><infon key="fpage">970</infon><infon key="issue">8</infon><infon key="kwd">anaemia non-pregnant women micronutrients supplementation Gambia</infon><infon key="lpage">977</infon><infon key="name_0">surname:Gulati;given-names:Ruchi</infon><infon key="name_1">surname:Bailey;given-names:Robin</infon><infon key="name_2">surname:Prentice;given-names:Andrew M.</infon><infon key="name_3">surname:Brabin;given-names:Bernard J.</infon><infon key="name_4">surname:Owens;given-names:Stephen</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">63</infon><infon key="year">2009</infon><offset>0</offset><text>Haematological effects of multimicronutrient supplementation in non-pregnant Gambian women</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>91</offset><text>Background/Objectives:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>114</offset><text>The use of multimicronutrient (MMN) supplementation to reduce the burden of anaemia in non-pregnant women of reproductive age has been little studied, particularly in Africa. The objective of the study was to evaluate haematological outcomes in non-pregnant, rural Gambian women of reproductive age, receiving daily MMN supplements for one-year.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>460</offset><text>Subjects/Methods:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>478</offset><text>The study in 293 women aged from 17 to 45 years old was nested within a double-blind, randomised placebo-controlled trial of periconceptional MMN supplementation [ISRCTN 13687662], using the United Nations International Multiple Micronutrient Preparation (UNIMMAP), received daily for one year or until conception. Red cell parameters and free erythrocyte protoporphyrin concentration were measured at baseline and after 12-months in those women who did not conceive.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>946</offset><text>Results:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>955</offset><text>Anaemic women (haemoglobin concentration &lt;12g/dL) were more likely to be older and in economic deficit at baseline. Mean change in haemoglobin concentration was +0.6Â±1.4g/dL in the intervention arm and â0.2Â±1.2g/dL in the placebo arm (p&lt;0.001). After supplementation with MMN the relative risk of anaemia (&lt;12g/dL) was 0.59 (0.46, 0.76) compared to placebo. Anaemic subjects at baseline showed an increase in mean haemoglobin from 10.6g/dL to 11.8g/L (p&lt;0.001) after MMN supplementation.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1447</offset><text>Conclusion:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1459</offset><text>MMN supplementation should be considered as a strategy for improving the micronutrient and haematological status of non-pregnant women of reproductive age.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1615</offset><text>INTRODUCTION</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1628</offset><text>Many women in low-income countries suffer from sub-optimal micronutrition as a consequence of eating diets which are often low in animal-source foods and which do not meet dynamic micronutrient requirements throughout the reproductive lifecycle. Although iron deficiency is the commonest cause of nutritional morbidity worldwide, in women of reproductive age concurrent deficiencies of vitamins A, C, B and folate also frequently occur and all contribute to an increased anaemia risk. The prevention of multiple micronutrient deficiencies as a strategy to reduce the risk of prenatal anaemia has been little studied and attention has tended to focus instead on iron supplementation during pregnancy, with conflicting results . There are few large intervention trials of multiple micronutrient supplementation in non-pregnant women of reproductive age and none have been conducted in Africa.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2519</offset><text>In The Gambia, as in other parts of sub-Saharan Africa, seasonal multiple micronutrient deficiencies are common, and maternal anaemia and its sequelae remain frequent problems, particularly in rural areas. In order to assess the effectiveness of MMN supplementation in anaemia prevention in rural Gambian women, we analysed a sub-sample of participants enrolled as part of a large MMN, placebo-controlled supplementation trial.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2947</offset><text>MATERIALS/SUBJECTS AND METHODS</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>2978</offset><text>Study design and intervention</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3008</offset><text>The current study was nested within the Periconceptional Multimicronutrient Supplementation Trial (PMMST) [ISRCTN 13687662], based in 31 rural Gambian villages of Kiang West under demographic surveillance by the UK Medical Research Council field station in Keneba and which ran between February 2005 and June 2008. Between March and July 2006, resident females aged 17-45y were identified from the demographic database and pre-randomised to receive daily supplementation with UNIMMAP or placebo. For ease of administration in the field, randomisation was to one of four colour-coded groups (2 for intervention; 2 for placebo), stratified by age. Researchers were blinded to subject allocation scheme and subjects and field staff knew only the colour-coded allocation groups. UNIMMAP is a balanced preparation of 15 vitamins and minerals formulated by an Expert Committee of the United Nations Children's Fund, World Health Organization and the United Nations University, primarily for use by pregnant and lactating women. The composition of UNIMMAP is shown in Table 1. Eligible females were invited to attend a recruitment clinic where informed consent was sought in writing from individuals or guardians, in the cases of girls under 18-years old. Consenting non-pregnant women who were menstruating, not breastfeeding an infant, not using contraception or not severely anaemic (haemoglobin concentration &lt; 7g/dL) were included in the trial. Exclusions were referred for clinical management as required. Women received 30 tablets according to their allocated intervention group and were instructed to take one tablet daily. They were also asked to attend weekly supplementation clinics held in their own villages when they were re-supplied with supplements. Compliance with supplementation was assessed by pill counts (compliance factor=ratio of the number of tablets apparently consumed / number of days enrolled in study). Information on morbidity and menstrual patterns was also recorded at these visits. Subjects were asked to notify fieldworkers of suspected pregnancy and following confirmation of pregnancy by study midwives, women were instructed to stop supplementation and no further supplements were issued. These women received a standard antenatal preparation of 60mg elemental iron and 250Î¼g of folic acid daily. They were followed in the antenatal study clinic at regular intervals until delivery. Women who did not conceive while enrolled in PMMST, had received at least one year of MMN supplementation or placebo and were still resident in the selected villages in Kiang West, were eligible for inclusion in the current study. Data collection for the current study took place between July and August 2007.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5733</offset><text>Permission for this study was obtained from the London School of Hygiene and Tropical Medicine Ethics Committee and the Gambian Government/MRC Joint Ethics Committee. The parent-trial was subjected to the scrutiny of an independent Data Safety and Monitoring Board and operated under the auspices of Good Clinical Practice guidelines (MRC 1999). MRC Keneba offers free primary health care to anyone who consults, in collaboration with the Gambian Government Lower River Divisional Health Team. Apart from the structured clinical contacts outlined (during which subjects were given transport and a meal) no additional benefits were provided to trial participants.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6396</offset><text>Study location and population</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6426</offset><text>Kiang West is a semi-arid area of savannah-scrubland with a rural population of 14 000 people, predominantly of the Mandinka tribe. HIV status was not assessed during this study but national sentinel data from antenatal clinics indicates a HIV prevalence of around 1%. The sub-sample was drawn from 12 of the original 31 villages, chosen on the grounds of their larger size and easier accessibility. They included the core research villages of the Keneba, Kanton Kunda and Manduar and 9 of the villages to the east and west of Keneba. This provided a broad yet manageable sample frame from within the original trial cohort, given the logistical constraints under which the current study was carried out. Consenting subjects who were present in the village on an allotted day were recruited. Anthropometry and blood samples were collected from participants during village visits</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7304</offset><text>Sample size</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7316</offset><text>Mean recruitment haemoglobin for the PMMST study was 11.7 g/dL, (SD 1.5 g/dL) for a population of 1156. A sample of 150 for each trial arm was required in order to detect a change in haemoglobin of 0.5 g/dL between study arms with 5% significance and 80% power.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7578</offset><text>Data and sample collection</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7605</offset><text>Individual informed consent was obtained in the local language by Gambian MRC fieldworkers. A thumbprint was requested from women who were unable to write. An information sheet in English was provided for women to take away. A questionnaire assessing marital status and socioeconomic status was carried out. Economic situation was assessed by ownership of radio and/or bicycle and information on perceived economic status. Participants were asked whether they considered the household's economic situation in the preceding year to have been always in deficit, occasionally deficit, balanced or surplus. A household was categorised as in âeconomic deficitâ if the subject answered either always deficit or occasionally deficit. A one-week dietary history, menstrual and medical history was completed for each subject. A stool sample was requested and sterile universal containers provided at the study visit following the trial. At initial recruitment within the main study baseline stool samples had not been collected. Venous blood was placed in EDTA, sedivette and serum tubes (Sarstedt Monovette, UK). Height was measured to the nearest cm using a stadiometer (Seca Leicester, UK), and weight to the nearest 100 g using an electronic scale (Tanita, USA). Mid-upper arm circumference (MUAC) was measured at the mid-point of the left arm using standard tapes (TALC, UK). Data were double entered into the MRC Keneba database (MS Access, Microsoft, USA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9064</offset><text>Laboratory analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9084</offset><text>Haematological analysis included haemoglobin concentration, white blood cell count, mean cell volume (MCV), mean cell haemoglobin (MCH), reticulocyte count (Cel-Dyn 3700 Analyser, Abbott Diagnostics, USA and Medonic CA530, Clinical Diagnostic Solutions, Inc., USA), and zinc protoporphyrin concentration (ZnPP) (AVIV ZP Hematofluorometer Model 206, Analis Scientific Instruments, Belgium). The erythrocyte sedimentation rate (ESR) (Sarstedt, UK) and C-reactive protein (CRP) (Vitros system 250, Johnson &amp; Johnson, USA) were measured. Malaria blood films were prepared and stained with giemsa stain and 100 microscopic fields examined to determine parasite count. Wet stool samples were prepared for examination by light microscopy for the presence of helminths.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9846</offset><text>Both Cell-dyn and Medonic CA530 analysers were used for processing of haematological samples due to a technical fault with the Cell-dyn machine. The correlation coefficient between the results for the two machines was 0.96 (p&lt;0.001).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10080</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10101</offset><text>Data was blinded until completion of the analysis, which was performed on an intention-to-treat basis. Data were processed and analysed using SPSS for Windows v15. Log transformation was used for non-normal distributions. Anaemia was defined as hemoglobin concentration less than 12 g/dL. Mean haemoglobin concentration change (baseline to follow-up) was compared between treatment groups with analysis of covariance. Variables which did not require adjustment for baseline values were compared using an independent t-test for continuous variables, Wilcoxon ranksum for non normally distributed variables (CRP) and a chi-squared test of proportions for categorical variables. The odds ratio (OR) and relative risk (RR) for anaemia in relation to MMN supplement, age and ESR were computed using logistic regression. Differences were considered significant at p&lt;0.05.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>10967</offset><text>RESULTS</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10975</offset><text>Of 1156 women recruited for the original trial 421 were considered to be eligible for the current study according to the criteria above. Of these 293 subjects were identified and recruited (Figure 1). Subjects who could not be traced by the field teams or who did not attend after direct invitation were not recruited (n=128). Baseline characteristics of recruited (n=293) and non-recruited (n=128) women are summarised in Table 2. Untraced women were more likely to be nulliparous, to have lower mean anthropometric indices and were more likely to have received formal schooling. There were no differences in haematological parameters. Baseline characteristics of the intervention and placebo groups were not different except for total white cell concentration at baseline (Table 3). The estimate of compliance did not differ between treatment groups (MMN: 0.96 Â± 0.18; placebo: 0.92 Â± 0.19, p=0.15). The mean time of follow up was similar in both groups (MMN: 14.1 Â± 1.2 months, placebo 14.0 Â± 1.2 months). Baseline predictors of anaemia, after adjustment (Table 4), included older age OR= 2.01 (1.16, 3.48) and economic deficit OR=1.98 (1.21, 3.25).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12132</offset><text>Following the intervention period mean haemoglobin concentration was higher in women receiving micronutrients (MMN: 12.3Â±1.1g/dL, placebo: 11.5Â±1.4g/dL) with a mean change in haemoglobin concentration of +0.6Â±1.4g/dL (MMN) and â0.2Â±1.2g/dL (placebo) (p&lt;0.001). The increase in haemoglobin concentration in the intervention group relative to placebo was more marked in women who were anaemic at the start of the study (Figure 2). Although age and economic deficit were predictors of anaemia at baseline, in a sub analysis these groups did not respond differently to supplementation. Table 3 includes the haematological findings at follow up. Supplementation was associated with increased haemoglobin concentration and MCV and reduced ZnPP concentration (all p&lt;0.001). The reduction in reticulocyte count was marginally significant (p=0.04). ESR was also noted to be lower in the MMN group than in the placebo group (22Â±13.5mm/hr versus 26Â±15.5mm/hr, p=0.02). Raised ESR values (&gt;20mm/hr) were less frequent in supplemented women OR 0.71 (0.55, 0.91).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13190</offset><text>There were no differences in anthropometric indices (BMI, weight, and MUAC) between the two groups (Table 3). No subjects had malaria parasitaemia at follow-up. Median CRP was 0 mg/L for both groups and there were no differences in proportion of women with a raised CRP (&gt;10g/L) in either group. Only one stool sample showed hookworm infection.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13535</offset><text>At baseline, anaemia prevalence was 50.7% (MMN group) and 54.1% (placebo group). Following supplementation these were 36% and 62% respectively, generating RR=0.59 (0.46, 0.76) for anaemia in the MMN group. Anaemia was less frequent in the MMN group (p&lt;0.001) and more frequent in older women (p=0.01) and there was no significant interaction between age and intervention group.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13913</offset><text>There were no significant differences in combined or system-specific morbidity profiles between study groups (data not shown).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>14040</offset><text>DISCUSSION</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14051</offset><text>To our knowledge this is the first African trial to evaluate the effect of multiple micronutrient supplementation on red cell parameters and iron status among non-pregnant women of reproductive age. Twelve months of daily MMN supplementation significantly improved haemoglobin concentration in this group of women. The associated decrease in ZnPP concentration and increased MCV in supplemented women suggests that the iron content of the supplements underpinned the improved haematological profile, while the differences in reticulocyte count suggest a reduction in red cell turnover among MMN supplemented women. Anaemia prevalence was almost halved in supplemented women and anaemic women showed the greatest increase in haemoglobin concentration following supplementation (+1.2g/dL). This would be expected as subjects who are iron-depleted use iron more effectively than those who are iron-replete.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14955</offset><text>ESR was measured in this study. ESR is a non-specific, indirect measurement of plasma acute-phase protein and systemic inflammatory status that is known to correlate with haemoglobin and plasma fibrinogen concentrations. It is influenced by the size, shape, and number of erythrocytes, as well as by other plasma constituents such as immunoglobulins. Interpretation of the effect of supplementation on ESR is complex but the reduction in ESR following supplementation could indicate a ameliorating effect of MMN on systemic inflammation. However, there was no direct evidence that CRP concentration was affected by micronutrient supplementation. More detailed studies of inflammatory markers and MMN supplementation are required in order to understand their roles in the aetiology of anaemia in this population of women, particularly in areas of high malarial endemicity.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15827</offset><text>The study was restricted to a sub-sample of geographically selected villages but this does not appear to have biased the results of the study, as the placebo and intervention groups were comparable at baseline. The high compliance, regular follow-up and long duration of our study further increases confidence in the findings. The placebo control group allowed for an absolute evaluation of the effects of micronutrients on haematological parameters. The primary analysis was powered to assess changes in haemoglobin concentration, which limited the scope of this study to the functional effect of MMN supplementation on nutritional anaemia. This outcome represented a simple, clinically relevant measure of composite micronutrient status, achievable within the time and resource constraints under which the nested study was carried out. However an analysis of the effects of supplementation on broader micronutrient status in this population would have been of interest and is a specified outcome in the main trial, which will be reported elsewhere. There was a low prevalence of malaria parasitaemia in the current study, which is likely to have been a consequence of cross-sectional sampling of partially immune adults early in the wet season, in an area of highly seasonal endemicity. Although there was no difference in the rate of clinical infection diagnosis between the two arms of the parent trial, longitudinal malaria exposure may have been an effect modifier or confounding variable in this study and ought to be assessed formally in future work.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17386</offset><text>Iron deficiency is an important risk factor for increased maternal mortality, low birth weight and preterm delivery and the availability of calcium, iodine, folate and vitamins A and D may modulate fetal development. In order to achieve Millennium Development Goals, new strategies to address nutritional problems in women of reproductive age are required. Several recent studies in poorer countries have already demonstrated improved parameters of fetal growth and gestational length with various prenatal MMN supplementation regimen, although effects have been inconsistent and the mechanisms of action are unclear. There are concerns about possible detrimental interactions between micronutrients combined within a single supplement but experimental data are sparse and the potential synergistic and positive effects of particular combinations should not be ignored. The timing of supplementation may likewise be a crucial factor. For example, the fact that prenatal folate supplementation substantially reduces the risk of neural tube defect only if it is taken preconceptually is well known but improving vitamin A status before pregnancy has also been shown to have a dramatic and as yet unexplained effect on maternal morbidity and mortality. Optimising the pre- and inter-pregnancy micronutritional status of women, particularly in low resource settings could be extremely beneficial and may lead to improved subsequent maternal and pregnancy outcomes.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18847</offset><text>Previous studies in Mexico and Bangladesh have shown no additional benefit on haematological parameters when women of reproductive age and adolescents were given MMN compared to iron-folate supplements. The duration of supplementation in these studies was short, different MMN formulations were used and sample sizes were smaller than in the present study. Neither trial utilised a placebo-controlled design, limiting the interpretation of the study results. The present study achieved a greater improvement in haemoglobin concentration and a greater decline in the prevalence of anaemia compared to these previous reports. The findings from the Bangladesh study did however provide additional support for the use of combinations of micronutrients in preference to iron alone, as the prevalence of other nutrient deficiencies including folic acid, riboflavin and vitamin B12, A and C were also decreased in addition to improved values for haematological parameters.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19813</offset><text>In Indonesia, the haemoglobin concentration of adolescent girls improved on supplementation with combinations of iron, folic acid, retinol and vitamin C, over placebo but did not respond better to daily rather that weekly supplementation, although serum ferritin increased more in the daily supplemented group. The intervention period was only 3-months, compared with 12-months in the present study, and there was a high dropout rate.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20248</offset><text>A study of Bangladeshi adolescents receiving a micronutrient fortified beverage 6d/week reported haematological effects which were of a similar magnitude to those in the current study. An increase in serum retinol and improved anthropometric status (weight, height, BMI) in supplemented girls was also recorded, indicating the potential benefits of MMN supplementation for a risk group attempting to satisfy increased nutritional requirements for pubertal growth while commonly manifesting a substantial degree of undernutrition. It has frequently been suggested that adolescents should be the focus of targeted intervention strategies which aim to improve reproductive health particularly before first pregnancies. Although the issue of supplementation in younger women is critical, they may be difficult to target over a long period of time and may not begin their reproductive lives proximal to the supplementation period.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21174</offset><text>The number of adolescents in the present study was small (n=23) and conclusions cannot readily be drawn concerning the haematological responses of this sub-group. By contrast, subjects were generally older, better nourished, multiparous and poorly educated. Two-thirds of untraced women were nulliparous compared with one third of the traced women, characterising a group of younger, more mobile but less reproductively-active women, akin to that in the Bangladeshi study.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21647</offset><text>We have rather shown that older, anaemic multiparae who are experiencing recurrent demands of pregnancy and lactation under seasonally adverse conditions clearly benefit from MMN supplementation. The findings of this study provide evidence of the efficacy of MMN supplementation and support its promotion in non-pregnant women as a means of optimising haematological and micronutrient status in between pregnancies, especially in relation to iron status. Community antenatal and paediatric clinics, which often already serve these populations, can readily be used to identify those at particular risk on finger-prick testing and target them for supplementation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22309</offset><text>There is now a small but growing body of data supporting the efficacy of prenatal multi-micronutrients in improving selected perinatal outcomes of women and babies in resource-poor settings. Studies specifically utilising UNIMMAP benefit from and contribute to datasets based on a uniform and targeted intervention, facilitating the interpretation and reproducibility of their results. Future studies should compare placebo, iron-folate and UNIMMAP supplementation in order to assess the efficacy and effectiveness of pre- or inter-pregnancy supplementation on later maternal anaemia and pregnancy outcome, as well as the impact on broader micronutrient status and other functional outcomes in this vulnerable group.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>23026</offset><text>REFERENCES</text></passage><passage><infon key="fpage">829</infon><infon key="lpage">835</infon><infon key="name_0">surname:Ahmed;given-names:F</infon><infon key="name_1">surname:Khan;given-names:MR</infon><infon key="name_2">surname:Akhtaruzzaman;given-names:M</infon><infon key="name_3">surname:Karim;given-names:R</infon><infon key="name_4">surname:Marks;given-names:GC</infon><infon key="name_5">surname:Banu;given-names:CP</infon><infon key="pub-id_pmid">16210713</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">82</infon><infon key="year">2005</infon><offset>23037</offset><text>Efficacy of twice-weekly multiple micronutrient supplementation for improving the hemoglobin and micronutrient status of anemic adolescent schoolgirls in Bangladesh</text></passage><passage><infon key="fpage">1280S</infon><infon key="lpage">1284S</infon><infon key="name_0">surname:Allen;given-names:LH</infon><infon key="pub-id_pmid">10799402</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="year">2000</infon><offset>23202</offset><text>Anemia and iron deficiency: effects on pregnancy outcome</text></passage><passage><infon key="fpage">177</infon><infon key="lpage">183</infon><infon key="name_0">surname:Angeles-Agdeppa;given-names:I</infon><infon key="name_1">surname:Schultink;given-names:W</infon><infon key="name_2">surname:Sastroamidjojo;given-names:S</infon><infon key="name_3">surname:Gross;given-names:R</infon><infon key="name_4">surname:Karyadi;given-names:D</infon><infon key="pub-id_pmid">9209187</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1997</infon><offset>23259</offset><text>Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents</text></passage><passage><infon key="fpage">510</infon><infon key="lpage">513</infon><infon key="name_0">surname:Anya;given-names:SE</infon><infon key="pub-id_pmid">15155982</infon><infon key="section_type">REF</infon><infon key="source">Am J Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2004</infon><offset>23350</offset><text>Seasonal variation in the risk and causes of maternal death in the Gambia: malaria appears to be an important factor</text></passage><passage><infon key="fpage">1188S</infon><infon key="lpage">1193S</infon><infon key="name_0">surname:Bartley;given-names:KA</infon><infon key="name_1">surname:Underwood;given-names:BA</infon><infon key="name_2">surname:Deckelbaum;given-names:RJ</infon><infon key="pub-id_pmid">15883450</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">2005</infon><offset>23467</offset><text>A life cycle micronutrient perspective for women's health</text></passage><passage><infon key="fpage">814</infon><infon key="lpage">817</infon><infon key="name_0">surname:Bates;given-names:CJ</infon><infon key="name_1">surname:Villard;given-names:L</infon><infon key="name_2">surname:Prentice;given-names:AM</infon><infon key="name_3">surname:Paul;given-names:AA</infon><infon key="name_4">surname:Whitehead;given-names:RG</infon><infon key="pub-id_pmid">6533855</infon><infon key="section_type">REF</infon><infon key="source">Trans R Soc Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">1984</infon><offset>23525</offset><text>Seasonal variations in plasma retinol and carotenoid levels in rural Gambian women</text></passage><passage><infon key="fpage">219</infon><infon key="lpage">240</infon><infon key="name_0">surname:Billewicz;given-names:WZ</infon><infon key="name_1">surname:McGregor;given-names:IA</infon><infon key="pub-id_pmid">7287780</infon><infon key="section_type">REF</infon><infon key="source">J Biosoc Sci</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1981</infon><offset>23608</offset><text>The demography of two West African (Gambian) villages, 1951--75</text></passage><passage><infon key="comment">discussion 614S-615S</infon><infon key="fpage">604S</infon><infon key="lpage">614S</infon><infon key="name_0">surname:Brabin;given-names:BJ</infon><infon key="name_1">surname:Hakimi;given-names:M</infon><infon key="name_2">surname:Pelletier;given-names:D</infon><infon key="pub-id_pmid">11160593</infon><infon key="section_type">REF</infon><infon key="source">J Nutr</infon><infon key="type">ref</infon><infon key="volume">131</infon><infon key="year">2001</infon><offset>23672</offset><text>An analysis of anemia and pregnancy-related maternal mortality</text></passage><passage><infon key="fpage">221</infon><infon key="lpage">227</infon><infon key="name_0">surname:Breckenridge;given-names:MA</infon><infon key="name_1">surname:Okpanachi;given-names:E</infon><infon key="pub-id_pmid">829733</infon><infon key="section_type">REF</infon><infon key="source">Afr J Med Med Sci</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1976</infon><offset>23735</offset><text>The erythrocyte sedimentation rate in healthy North Nigerian university students</text></passage><passage><infon key="fpage">1443</infon><infon key="lpage">1450</infon><infon key="name_0">surname:Brigden;given-names:ML</infon><infon key="pub-id_pmid">10524488</infon><infon key="section_type">REF</infon><infon key="source">Am Fam Physician</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">1999</infon><offset>23816</offset><text>Clinical utility of the erythrocyte sedimentation rate</text></passage><passage><infon key="fpage">571</infon><infon key="name_0">surname:Christian;given-names:P</infon><infon key="name_1">surname:Khatry;given-names:SK</infon><infon key="name_2">surname:Katz;given-names:J</infon><infon key="name_3">surname:Pradhan;given-names:EK</infon><infon key="name_4">surname:LeClerq;given-names:SC</infon><infon key="name_5">surname:Shrestha;given-names:SR</infon><infon key="pub-id_pmid">12637400</infon><infon key="section_type">REF</infon><infon key="source">Bmj</infon><infon key="type">ref</infon><infon key="volume">326</infon><infon key="year">2003</infon><offset>23871</offset><text>Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial</text></passage><passage><infon key="fpage">1423</infon><infon key="lpage">1431</infon><infon key="name_0">surname:Fawzi;given-names:WW</infon><infon key="name_1">surname:Msamanga;given-names:GI</infon><infon key="name_2">surname:Urassa;given-names:W</infon><infon key="name_3">surname:Hertzmark;given-names:E</infon><infon key="name_4">surname:Petraro;given-names:P</infon><infon key="name_5">surname:Willett;given-names:WC</infon><infon key="pub-id_pmid">17409323</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">356</infon><infon key="year">2007</infon><offset>24005</offset><text>Vitamins and perinatal outcomes among HIV-negative women in Tanzania</text></passage><passage><infon key="fpage">448</infon><infon key="lpage">454</infon><infon key="name_0">surname:Gabay;given-names:C</infon><infon key="name_1">surname:Kushner;given-names:I</infon><infon key="pub-id_pmid">9971870</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">340</infon><infon key="year">1999</infon><offset>24074</offset><text>Acute-phase proteins and other systemic responses to inflammation</text></passage><passage><infon key="name_0">surname:Huffman;given-names:SL</infon><infon key="name_1">surname:Shumann;given-names:J</infon><infon key="name_2">surname:ER;given-names:Z</infon><infon key="section_type">REF</infon><infon key="source">The LINKAGES Project</infon><infon key="type">ref</infon><infon key="year">1998</infon><offset>24140</offset><text>The case for promoting multiple vitamin/mineral supplements for women of reproductive age in developing countries</text></passage><passage><infon key="fpage">1065</infon><infon key="lpage">1070</infon><infon key="name_0">surname:Hyder;given-names:SM</infon><infon key="name_1">surname:Persson;given-names:LA</infon><infon key="name_2">surname:Chowdhury;given-names:M</infon><infon key="name_3">surname:Lonnerdal;given-names:BO</infon><infon key="name_4">surname:Ekstrom;given-names:EC</infon><infon key="pub-id_pmid">15548345</infon><infon key="section_type">REF</infon><infon key="source">Public Health Nutr</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2004</infon><offset>24254</offset><text>Anaemia and iron deficiency during pregnancy in rural Bangladesh</text></passage><passage><infon key="fpage">2147</infon><infon key="lpage">2153</infon><infon key="name_0">surname:Hyder;given-names:SM</infon><infon key="name_1">surname:Haseen;given-names:F</infon><infon key="name_2">surname:Khan;given-names:M</infon><infon key="name_3">surname:Schaetzel;given-names:T</infon><infon key="name_4">surname:Jalal;given-names:CS</infon><infon key="name_5">surname:Rahman;given-names:M</infon><infon key="pub-id_pmid">17709456</infon><infon key="section_type">REF</infon><infon key="source">J Nutr</infon><infon key="type">ref</infon><infon key="volume">137</infon><infon key="year">2007</infon><offset>24319</offset><text>A multiple-micronutrient-fortified beverage affects hemoglobin, iron, and vitamin A status and growth in adolescent girls in rural Bangladesh</text></passage><passage><infon key="fpage">1081</infon><infon key="lpage">1089</infon><infon key="name_0">surname:Kaestel;given-names:P</infon><infon key="name_1">surname:Michaelsen;given-names:KF</infon><infon key="name_2">surname:Aaby;given-names:P</infon><infon key="name_3">surname:Friis;given-names:H</infon><infon key="pub-id_pmid">16015266</infon><infon key="section_type">REF</infon><infon key="source">Eur J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">2005</infon><offset>24461</offset><text>Effects of prenatal multimicronutrient supplements on birth weight and perinatal mortality: a randomised, controlled trial in Guinea-Bissau</text></passage><passage><infon key="fpage">16</infon><infon key="lpage">18</infon><infon key="name_0">surname:Kanfer;given-names:EJ</infon><infon key="name_1">surname:Nicol;given-names:BA</infon><infon key="pub-id_pmid">9059375</infon><infon key="section_type">REF</infon><infon key="source">J R Soc Med</infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">1997</infon><offset>24601</offset><text>Haemoglobin concentration and erythrocyte sedimentation rate in primary care patients</text></passage><passage><infon key="name_0">surname:Leenstra;given-names:T</infon><infon key="name_1">surname:Kariuki;given-names:SK</infon><infon key="name_2">surname:Kurtis;given-names:JD</infon><infon key="name_3">surname:Oloo;given-names:AJ</infon><infon key="name_4">surname:Kager;given-names:PA</infon><infon key="name_5">surname:Ter Kuile;given-names:FO</infon><infon key="section_type">REF</infon><infon key="source">Eur J Clin Nutr</infon><infon key="type">ref</infon><infon key="year">2007</infon><offset>24687</offset><text>The effect of weekly iron and vitamin A supplementation on hemoglobin levels and iron status in adolescent schoolgirls in western Kenya</text></passage><passage><infon key="fpage">1308</infon><infon key="lpage">1311</infon><infon key="name_0">surname:Moriarty-Craige;given-names:SE</infon><infon key="name_1">surname:Ramakrishnan;given-names:U</infon><infon key="name_2">surname:Neufeld;given-names:L</infon><infon key="name_3">surname:Rivera;given-names:J</infon><infon key="name_4">surname:Martorell;given-names:R</infon><infon key="pub-id_pmid">15531680</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">80</infon><infon key="year">2004</infon><offset>24823</offset><text>Multivitamin-mineral supplementation is not as efficacious as is iron supplementation in improving hemoglobin concentrations in nonpregnant anemic women living in Mexico</text></passage><passage><infon key="fpage">103</infon><infon key="lpage">104</infon><infon key="name_0">surname:Owens;given-names:S</infon><infon key="name_1">surname:Fall;given-names:CH</infon><infon key="pub-id_pmid">17996910</infon><infon key="section_type">REF</infon><infon key="source">Trans R Soc Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2008</infon><offset>24993</offset><text>Consequences of poor maternal micronutrition before and during early pregnancy</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">425</infon><infon key="name_0">surname:Powers;given-names:HJ</infon><infon key="name_1">surname:Bates;given-names:CJ</infon><infon key="pub-id_pmid">3686638</infon><infon key="section_type">REF</infon><infon key="source">Trans R Soc Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">1987</infon><offset>25072</offset><text>Micronutrient deficiencies in the aetiology of anaemia in a rural area in The Gambia</text></passage><passage><infon key="fpage">CD003094</infon><infon key="name_0">surname:Reveiz;given-names:L</infon><infon key="name_1">surname:Gyte;given-names:GM</infon><infon key="name_2">surname:Cuervo;given-names:LG</infon><infon key="pub-id_pmid">17443522</infon><infon key="section_type">REF</infon><infon key="source">Cochrane Database Syst Rev</infon><infon key="type">ref</infon><infon key="year">2007</infon><offset>25157</offset><text>Treatments for iron-deficiency anaemia in pregnancy</text></passage><passage><infon key="fpage">S181</infon><infon key="issue">Suppl 2</infon><infon key="lpage">185</infon><infon key="name_0">surname:Sandstrom;given-names:B</infon><infon key="pub-id_pmid">11509108</infon><infon key="section_type">REF</infon><infon key="source">Br J Nutr</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">2001</infon><offset>25209</offset><text>Micronutrient interactions: effects on absorption and bioavailability</text></passage><passage><infon key="fpage">1841</infon><infon key="lpage">1846</infon><infon key="name_0">surname:Schim van;given-names:der</infon><infon key="name_1">surname:Loeff;given-names:MF</infon><infon key="name_2">surname:Sarge-Njie;given-names:R</infon><infon key="name_3">surname:Ceesay;given-names:S</infon><infon key="name_4">surname:Awasana;given-names:AA</infon><infon key="name_5">surname:Jaye;given-names:P</infon><infon key="name_6">surname:Sam;given-names:O</infon><infon key="pub-id_pmid">12891071</infon><infon key="section_type">REF</infon><infon key="source">AIDS</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2003</infon><offset>25279</offset><text>Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women</text></passage><passage><infon key="fpage">S99</infon><infon key="lpage">103</infon><infon key="name_0">surname:Stoltzfus;given-names:RJ</infon><infon key="pub-id_pmid">17016951</infon><infon key="section_type">REF</infon><infon key="source">Food Nutr Bull</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2003</infon><offset>25385</offset><text>Iron deficiency: global prevalence and consequences</text></passage><passage><infon key="fpage">595</infon><infon key="lpage">601</infon><infon key="name_0">surname:Topley;given-names:E</infon><infon key="pub-id_pmid">5707913</infon><infon key="section_type">REF</infon><infon key="source">Trans R Soc Trop Med Hyg</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">1968</infon><offset>25437</offset><text>Common anaemia in rural gambia. II. Iron deficiency anaemia among women</text></passage><passage><infon key="comment">Report of an UNICEF/WHO/UNU workshop</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">1999</infon><offset>25509</offset><text>Composition of a multi-micronutrient supplement to be used in pilot programmes among pregnant women in developing countries</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2001</infon><offset>25633</offset><text>Iron Deficiency Anaemia Assessment, Prevention and Control: A guide for programme managers</text></passage><passage><infon key="fpage">570</infon><infon key="lpage">575</infon><infon key="name_0">surname:West;given-names:KP;suffix:Jr.</infon><infon key="name_1">surname:Katz;given-names:J</infon><infon key="name_2">surname:Khatry;given-names:SK</infon><infon key="name_3">surname:LeClerq;given-names:SC</infon><infon key="name_4">surname:Pradhan;given-names:EK</infon><infon key="name_5">surname:Shrestha;given-names:SR</infon><infon key="pub-id_pmid">10037634</infon><infon key="section_type">REF</infon><infon key="source">Bmj</infon><infon key="type">ref</infon><infon key="volume">318</infon><infon key="year">1999</infon><offset>25724</offset><text>Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group</text></passage><passage><infon key="file">ukmss-3579-f0001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>25891</offset><text>Trial Profile: subjects entering PMMST and further enrolment into the haematological sub-study</text></passage><passage><infon key="file">ukmss-3579-f0002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>25986</offset><text>Comparison of haemoglobin change in MMN and placebo groups in relation to baseline haemoglobin concentration</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>26095</offset><text>Composition of the United Nations International Multiple Micronutrient Preparation (UNIMMAP)</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Micronutrient&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dose*&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin A&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;800RE&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin D&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;200IU&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin E&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin C&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;70mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin B1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.4mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin B2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.4mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Niacin&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin B6&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.9mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vitamin B12&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.6mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Folic Acid&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;400Î¼g&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Iron&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;30mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Zinc&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Copper&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Selenium&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;65Î¼g&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Iodine&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;150Î¼g&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>26188</offset><text>Micronutrient	Dose*	 	Vitamin A	800RE	 	Vitamin D	200IU	 	Vitamin E	10mg	 	Vitamin C	70mg	 	Vitamin B1	1.4mg	 	Vitamin B2	1.4mg	 	Niacin	18mg	 	Vitamin B6	1.9mg	 	Vitamin B12	2.6mg	 	Folic Acid	400Î¼g	 	Iron	30mg	 	Zinc	15mg	 	Copper	2mg	 	Selenium	65Î¼g	 	Iodine	150Î¼g	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>26462</offset><text>Doses are based on US/Canadian recommended daily allowances in pregnancy.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>26536</offset><text>Characteristics of recruited and non-recruited eligible subjects prior to intervention period</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Untraced Women&lt;break/&gt; n=128&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Traced Women&lt;break/&gt; n=293&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p value&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th colspan=&quot;4&quot; align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot;&gt;
&lt;hr/&gt;
&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th colspan=&quot;4&quot; align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot;&gt;Characteristics&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Age (yrs)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25.2Â±7.9&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32.4Â±8.7&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;BMI (kg/m&lt;sup&gt;2&lt;/sup&gt;)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21.1Â±3.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.3Â±4.4&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.03&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Weight (kg)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54.6Â±9.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;57.1Â±11.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.007&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;MUAC (mm)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;259.5Â±28.6&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;268.9Â±37.9&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.012&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Proportion nulliparous&lt;/bold&gt;
&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN1&quot;&gt;1&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.66(0.58,0.74)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.30(0.25,0.35)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Formal schooling&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN1&quot;&gt;1&lt;/xref&gt;
&lt;bold&gt;(proportion)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.33(0.24,0.41)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.10(0.07,0.13)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Meat or fish eaten (d/wk)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.9Â±2.0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.5Â±1.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.04&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Haemoglobin&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN2&quot;&gt;2&lt;/xref&gt;
&lt;bold&gt;(g/dL)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.9Â±1.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.7Â±1.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.18&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;MCV&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN2&quot;&gt;2&lt;/xref&gt;
&lt;bold&gt;(fl)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;80.6Â±8.02&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;81.7Â±7.91&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.22&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;MCH&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN2&quot;&gt;2&lt;/xref&gt;
&lt;bold&gt;(pg)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27.6Â±3.3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27.9Â±3.28&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.30&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;ZnPP&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN2&quot;&gt;2&lt;/xref&gt;,&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN3&quot;&gt;3&lt;/xref&gt;
&lt;bold&gt;(Î¼mol/mol heme)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;97.9(87.5,109.3)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;87.9(79.3,97.3)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.09&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Malaria film positive&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN4&quot;&gt;4&lt;/xref&gt;
&lt;bold&gt;(no)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.89&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Totalwhite cells (Ã10&lt;sup&gt;9&lt;/sup&gt;/L)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.19Â±1.21&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.87Â±1.33&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.02&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Reticulocyte&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN2&quot;&gt;2&lt;/xref&gt;
&lt;bold&gt;%&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.64Â±0.68&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.58Â±0.52&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.30&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>26630</offset><text>	Untraced Women n=128	Traced Women n=293	p value	 		 	Characteristics	 	Age (yrs)	25.2Â±7.9	32.4Â±8.7	&lt;0.001	 	BMI (kg/m2)	21.1Â±3.2	22.3Â±4.4	0.03	 	Weight (kg)	54.6Â±9.5	57.1Â±11.5	0.007	 	MUAC (mm)	259.5Â±28.6	268.9Â±37.9	0.012	 	Proportion nulliparous1	0.66(0.58,0.74)	0.30(0.25,0.35)	&lt;0.001	 	Formal schooling1(proportion)	0.33(0.24,0.41)	0.10(0.07,0.13)	&lt;0.001	 	Meat or fish eaten (d/wk)	3.9Â±2.0	4.5Â±1.8	0.04	 	Haemoglobin2(g/dL)	11.9Â±1.5	11.7Â±1.5	0.18	 	MCV2(fl)	80.6Â±8.02	81.7Â±7.91	0.22	 	MCH2(pg)	27.6Â±3.3	27.9Â±3.28	0.30	 	ZnPP2,3(Î¼mol/mol heme)	97.9(87.5,109.3)	87.9(79.3,97.3)	0.09	 	Malaria film positive4(no)	0	3	0.89	 	Totalwhite cells (Ã109/L)	5.19Â±1.21	4.87Â±1.33	0.02	 	Reticulocyte2%	1.64Â±0.68	1.58Â±0.52	0.30	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>27374</offset><text>Proportions and 95% confidence intervals given, Chi test performed</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>27441</offset><text>Only 127 in untraced group and 292 in traced group baseline haematological samples not being available</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>27544</offset><text>Geometric means</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>27560</offset><text>Only 127 in untraced group and 283 in traced group baseline samples not being available</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>27648</offset><text>Characteristics of subjects at baseline and after intervention</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Characteristics&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;underline&gt;MMN&lt;/underline&gt;
&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;underline&gt;Placebo&lt;/underline&gt;
&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Baseline&lt;break/&gt; n=145&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;After intervention&lt;break/&gt; n=142&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN5&quot;&gt;1&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Baseline&lt;break/&gt; n=148&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;After intervention&lt;break/&gt; n=148&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN6&quot;&gt;2&lt;/xref&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Age (yrs)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;33 Â±8.6&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;34 Â±8.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Proportion nulliparous&lt;/bold&gt;
&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN7&quot;&gt;3&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.35(0.27,0.43)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.25(0.18,0.32)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Formal schooling&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN7&quot;&gt;3&lt;/xref&gt;
&lt;bold&gt;(proportion)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.12(0.06, 0.17)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.09(0.04,0.13)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Meat or fish eaten (d/wk)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.6 Â±1.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.4 Â±1.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;No of months in study&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14.1Â±1.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14.0Â±1.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Malaria film positive&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN8&quot;&gt;4&lt;/xref&gt;
&lt;bold&gt;(no)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;BMI (kg/m&lt;sup&gt;2&lt;/sup&gt;)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.4 Â±5.0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23 Â±5.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.1 Â±3.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.6 Â±4.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.49&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Weight (kg)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;57.4 Â±12.1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;59.0 Â±12.9&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;56.7 Â±10.9&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;58.0 Â±11.8&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.49&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;MUAC (mm)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;269.7 Â±41.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;280.1 Â±44.0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;267.8 Â±34.6&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;275.1 Â±37&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.30&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Haemoglobin (g/dL)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.7 Â±1.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12.3 Â± 1.1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.6 Â±1.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.5Â±1.4&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;MCV (fl)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;81.2 Â±8.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;81.9 Â±6.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;82.1 Â±7.3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;80.6 Â±7.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;MCH (pg)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27.8 Â±3.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32.0 Â±3.9&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;28.1 Â±3.1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32.0 Â±4.4&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.76&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;ZnPP&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN9&quot;&gt;5&lt;/xref&gt;,&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN10&quot;&gt;6&lt;/xref&gt;
&lt;bold&gt;(Î¼mol/mol heme)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;89.5(86.0,93.0)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54.0(52.2,56.8)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;86.4(82.8,90.0)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;72.2(68.5,75.9)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Totalwhite cells (Ã10&lt;sup&gt;9&lt;/sup&gt;/L)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.02Â±1.30&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.03 Â±2.1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.71Â±1.35 5.03 Â±2.1&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.50 Â±2.0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.08&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Reticulocyte %&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.64 Â± 0.62&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.60 Â±0.56&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.51 Â± 0.40&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.56 Â±0.41&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.04&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;ESR&lt;/bold&gt;&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN11&quot;&gt;7&lt;/xref&gt;
&lt;bold&gt;(mm/hr)&lt;/bold&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22 Â±13.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26 Â±15.5&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.02&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN12&quot;&gt;8&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;CRP&lt;/bold&gt;
&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;TFN13&quot;&gt;9&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.73&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>27711</offset><text>Characteristics	MMN		Placebo			 		Baseline n=145	After intervention n=1421	Baseline n=148	After intervention n=148	p2	 	Age (yrs)	33 Â±8.6	-	34 Â±8.8	-	-	 	Proportion nulliparous3	0.35(0.27,0.43)	-	0.25(0.18,0.32)	-	-	 	Formal schooling3(proportion)	0.12(0.06, 0.17)	-	0.09(0.04,0.13)	-	-	 	Meat or fish eaten (d/wk)	4.6 Â±1.8	-	4.4 Â±1.8	-	-	 	No of months in study	14.1Â±1.2	-	14.0Â±1.2	-	-	 	Malaria film positive4(no)	0	0	3	0	-	 	BMI (kg/m2)	22.4 Â±5.0	23 Â±5.2	22.1 Â±3.8	22.6 Â±4.2	0.49	 	Weight (kg)	57.4 Â±12.1	59.0 Â±12.9	56.7 Â±10.9	58.0 Â±11.8	0.49	 	MUAC (mm)	269.7 Â±41.2	280.1 Â±44.0	267.8 Â±34.6	275.1 Â±37	0.30	 	Haemoglobin (g/dL)	11.7 Â±1.5	12.3 Â± 1.1	11.6 Â±1.5	11.5Â±1.4	&lt;0.001	 	MCV (fl)	81.2 Â±8.5	81.9 Â±6.2	82.1 Â±7.3	80.6 Â±7.2	&lt;0.001	 	MCH (pg)	27.8 Â±3.5	32.0 Â±3.9	28.1 Â±3.1	32.0 Â±4.4	0.76	 	ZnPP5,6(Î¼mol/mol heme)	89.5(86.0,93.0)	54.0(52.2,56.8)	86.4(82.8,90.0)	72.2(68.5,75.9)	&lt;0.001	 	Totalwhite cells (Ã109/L)	5.02Â±1.30	5.03 Â±2.1	4.71Â±1.35 5.03 Â±2.1	4.50 Â±2.0	0.08	 	Reticulocyte %	1.64 Â± 0.62	1.60 Â±0.56	1.51 Â± 0.40	1.56 Â±0.41	0.04	 	ESR7(mm/hr)	-	22 Â±13.5	-	26 Â±15.5	0.028	 	CRP9	-	0	-	0	0.73	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>28857</offset><text>142 samples as baseline sample not available for one subject, and 2 subjects did not have samples taken at follow up</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>28974</offset><text>Analysis of covariance unless otherwise stated. P-values refer to change in mean values between baseline and after intervention and not to the absolute values that are given in the table</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29161</offset><text>Proportions and 95% confidence intervals given, Chi test performed</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29228</offset><text>Fishers exact test</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29247</offset><text>Only 144 subjects in MMN group at baseline as one sample not available</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29318</offset><text>Geometric means given</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29340</offset><text>Only 147 samples in placebo group due a to clotted sample</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29398</offset><text>Student t-test</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>29413</offset><text>Non-parametric tests, Wilcoxon ranksum, median values quoted</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>29474</offset><text>Predictors of haemoglobin &lt;12g/dL at baseline</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Odds Ratio (CI)&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Adjusted Odds Ratio (CI)&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Age &amp;gt;35 yrs&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.37 (1.54, 3.80)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.01 (1.16, 3.48)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.012&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Nulliparous&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.48 (0.2, 0.80)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.005&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.74 (0.40, 1.32)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.29&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Economic deficit&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.05 (1.27, 3.33)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.04&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.98 (1.21, 3.25)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.007&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;MUAC (&amp;lt;21cm)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.22 (0.27, 5.54)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.799&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;Meat (&amp;gt; once a week)&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.53 (0.19, 1.50)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.23&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;bold&gt;No formal schooling&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.75 (0.81, 3.77)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.16&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>29520</offset><text>	Odds Ratio (CI)	p	Adjusted Odds Ratio (CI)	p	 	Age &gt;35 yrs	2.37 (1.54, 3.80)	&lt;0.001	2.01 (1.16, 3.48)	0.012	 	Nulliparous	0.48 (0.2, 0.80)	0.005	0.74 (0.40, 1.32)	0.29	 	Economic deficit	2.05 (1.27, 3.33)	0.04	1.98 (1.21, 3.25)	0.007	 	MUAC (&lt;21cm)	1.22 (0.27, 5.54)	0.799			 	Meat (&gt; once a week)	0.53 (0.19, 1.50)	0.23			 	No formal schooling	1.75 (0.81, 3.77)	0.16			 	</text></passage></document></collection>
